Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Johnson & Johnson Boosts Dividend 6.1%
Yahoo/Zacks
Saturday, April 26, 2014 - 9:17am
tags:
JNJ
Illumina Files New Patent Infringement Suit Against Ariosa Diagnostics, Inc.
Yahoo/BusinessWire
Saturday, April 26, 2014 - 9:15am
tags:
Illumina, Ariosa, Harmony Prenatal Test
Arena Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month
Seeking Alpha
Saturday, April 26, 2014 - 9:00am
tags:
Arena Pharmaceuticals
Arena - Script Sales Start Recovery As Television Ads Hit Air
Seeking Alpha
Saturday, April 26, 2014 - 8:59am
tags:
Belviq, Arena Pharmaceuticals, weight loss, obesity
Mylan Said to Raise Offer for Swedish Drugmaker Meda
Bloomberg
Friday, April 25, 2014 - 3:27pm
tags:
M&A, Mylan, Meda
3 Questions About a Big Pharma Megamerger
Motley Fool
Friday, April 25, 2014 - 3:24pm
tags:
M&A, Pfizer, AstraZeneca, Big Pharma, palbociclib
Drug innovation: In the recovery room
FT.com
Friday, April 25, 2014 - 3:21pm
tags:
innovation, Roche, Novartis, GSK, Merck, Bristol-Myers Squibb
XenoPort Activist Urges Shareholders ‘Insist on Change’
Bloomberg
Friday, April 25, 2014 - 11:26am
tags:
XenoPort, restless legs syndrome, Horizant
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix
Seeking Alpha
Friday, April 25, 2014 - 11:21am
tags:
antibiotics, Cubist Pharma, Durata Therapeutics, Cellceutix
FDA will meet to review behavior changes and psychiatric risks of Pfizer's stop-smoking drug
Yahoo/AP
Friday, April 25, 2014 - 11:20am
tags:
FDA, Pfizer, Chantix, smoking cessation
Chinese Pharma Looks Healthy as Price Controls Ease, Consumers Spend More
TheStreet.com
Friday, April 25, 2014 - 11:19am
tags:
China
EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar
Yahoo/Reuters
Friday, April 25, 2014 - 11:02am
tags:
GSK, melanoma, Europe, Bayer, Nexavar, Mekinist, thyroid cancer
Allergan made a pass at Shire before Valeant came calling
Fierce Biotech
Friday, April 25, 2014 - 9:53am
tags:
Valeant Pharmaceuticals, M&A, Allergan, Shire
Allergan can do better than Valeant offer, investor says
Mass Device
Friday, April 25, 2014 - 9:18am
tags:
Valeant Pharmaceuticals, Allergan, M&A
C.R. Bard blows away sales and earnings expectations in Q1
Mass Device
Friday, April 25, 2014 - 9:17am
tags:
CR Bard, earnings, devices
BMS extends deal with Samsung as its pipeline percolates with more biologics
Fierce Pharma
Friday, April 25, 2014 - 9:08am
tags:
Bristol-Myers Squibb, Samsung BioLogics
Sarepta's Still a Gamble, Even With FDA Reversal
Motley Fool
Friday, April 25, 2014 - 8:31am
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Emergent's BioThrax Gets Orphan Drug Status
Yahoo/Zacks.com
Friday, April 25, 2014 - 8:27am
tags:
Emergent BioSolutions, BioThrax, orphan drugs, anthrax, vaccines
Cytokinetics says Lou Gehrig's drug fails mid-stage trial
Yahoo/Reuters
Friday, April 25, 2014 - 8:22am
tags:
Lou Gehrig's disease, Cytokinetics, ALS, Tirasemtiv
AbbVie shares rise after earnings top forecasts
Marketwatch
Friday, April 25, 2014 - 8:18am
tags:
AbbVie, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.